BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.73% |
| 2 | Financials | 5.47% |
| 3 | Healthcare | 4.96% |
| 4 | Consumer Discretionary | 4.64% |
| 5 | Industrials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Clean Energy Fuels
CLNE
$395M
| $76.5K | ﹤0.01% |
32,685
+11,068
| +51% | +$23.5K |
|
|
NETI
3302
DELISTED
Eneti Inc.
NETI
| $76.2K | ﹤0.01% |
1,196
+275
| +30% | +$16.7K |
|
|
PCSB
3303
DELISTED
PCSB Financial Corporation
PCSB
| $76K | ﹤0.01% |
3,752
+1,119
| +42% | +$22.6K |
|
|
TVRD
3304
Tvardi Therapeutics
TVRD
$22.4M
| $75.9K | ﹤0.01% |
131
-34
| -21% | -$23.9K |
|
|
EIDX
3305
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $75.8K | ﹤0.01% |
1,321
-634
| -32% | -$31.4K |
|
3306
Bridgewater Bancshares
BWB
$621M
| $75.6K | ﹤0.01% |
5,489
+1,702
| +45% | +$21.6K |
|
|
ORC
3307
Orchid Island Capital
ORC
$1.32B
| $75.6K | ﹤0.01% |
2,585
+720
| +39% | +$20.6K |
|
3308
Midland States Bancorp
MSBI
$698M
| $75.5K | ﹤0.01% |
2,607
-825
| -24% | -$22.7K |
|
3309
The Bancorp
TBBK
$2.82B
| $75.4K | ﹤0.01% |
5,814
-2,186
| -27% | -$24.5K |
|
3310
Bally's
BALY
$660M
| $75.2K | ﹤0.01% |
2,933
-85
| -3% | -$2.05K |
|
|
CATC
3311
DELISTED
CAMBRIDGE BANCORP
CATC
| $75.2K | ﹤0.01% |
938
+302
| +47% | +$23.5K |
|
|
STXB
3312
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $75.2K | ﹤0.01% |
3,268
+1,557
| +91% | +$34.3K |
|
3313
KT
KT
$9.04B
| $75.1K | ﹤0.01% |
6,472
| – | – |
|
|
TSC
3314
DELISTED
TriState Capital Holdings, Inc.
TSC
| $74.9K | ﹤0.01% |
2,867
-1,084
| -27% | -$25.8K |
|
|
BRSL
3315
Brightstar Lottery PLC
BRSL
$2.15B
| $74.9K | ﹤0.01% |
5,001
-994,204
| -99% | -$14.2M |
|
3316
First Bancorp
FNLC
$401M
| $74.8K | ﹤0.01% |
2,476
+831
| +51% | +$23.7K |
|
|
DVAX
3317
DELISTED
Dynavax Technologies
DVAX
| $74.8K | ﹤0.01% |
13,069
+733
| +6% | +$3.92K |
|
3318
Business First Bancshares
BFST
$1.05B
| $74.3K | ﹤0.01% |
2,979
+1,198
| +67% | +$29.4K |
|
|
EBTC
3319
DELISTED
Enterprise Bancorp
EBTC
| $74.1K | ﹤0.01% |
2,188
+665
| +44% | +$20.6K |
|
3320
Home Bancorp
HBCP
$570M
| $73.7K | ﹤0.01% |
1,881
+620
| +49% | +$24.1K |
|
3321
Calix
CALX
$2.51B
| $73.5K | ﹤0.01% |
9,190
+1,974
| +27% | +$14.7K |
|
|
LGF.A
3322
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $73.4K | ﹤0.01% |
6,889
-11,237
| -62% | -$104K |
|
3323
CRISPR Therapeutics
CRSP
$5.22B
| $73.4K | ﹤0.01% |
1,205
-23,577
| -95% | -$1.29M |
|
3324
Alector
ALEC
$228M
| $73.1K | ﹤0.01% |
4,242
-164
| -4% | -$2.79K |
|
|
BVH
3325
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $72.8K | ﹤0.01% |
3,051
+960
| +46% | +$22.1K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.